Pegylated Recombinant Human Erythropoietin is an erythropoiesis-stimulating agent used to treat anemia due to chronic kidney disease and cancer. It works by stimulating red blood cell production. Pegylated Recombinant Human Erythropoietin is clinically significant for managing anemia. In summary, it is essential for improving hemoglobin levels.
Pegylated Recombinant Human Erythropoietin binds to erythropoietin receptors in the bone marrow, stimulating erythropoiesis and increasing red blood cell production.


